Synthetic Blood Helps Stem Massive Hemorrhages

The artificial blood can be stored at normal room temperatures for more than a year.

To test the synthetic blood, the researchers first instigated thrombocytopenia in 10 rabbits by repeated blood withdrawal and isovolemic transfusion with autologous RBCs. Lethal traumatic hemorrhage was then induced by non-compressible penetrating liver injury. Subsequently, the encapsulated liposomes were administered to stop bleeding, achieving 100% hemostasis in all animals. The subsequent HbV administration rescued 75% of the rabbits from fatal anemia. The study was published in the October 2019 issue of Transfusion.

“The blood types of patients must be confirmed before they can receive transfusions, so emergency medical technicians and other health care workers are prohibited from transfusing blood in ambulances. Since blood type is not an issue with the artificial blood, injured patients can be treated before they arrive at hospitals, resulting in a higher survival rate,” said study co-author immunologist Manabu Kinoshita, PhD, of NDMC, to Asahi Shimbun. “It is difficult to stock a sufficient amount of blood for transfusions in such regions as remote islands. The artificial blood will be able to save the lives of people who otherwise could not be saved.”

Blood shortage is a global healthcare problem, and is likely to become even more problematic as people live longer and donor numbers dwindle.

Related Links:
National Defense Medical College
Waseda University
Nara Medical